BMO Capital Starts Pacira Pharmaceuticals (PCRX) at Underperform
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.18 -2.19%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
BMO Capital initiated coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with an Underperform rating and a price target of $36.00.
For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $37.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
